Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1942
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines ; volume:43 ; number:11 ; day:10 ; month:9 ; year:2020 ; pages:1089-1104 ; date:11.2020
Drug safety ; 43, Heft 11 (10.9.2020), 1089-1104, 11.2020
- Creator
-
Arlegui, Hugo
Bollaerts, Kaatje
Salvo, Francesco
Bauchau, Vincent
Nachbaur, Gaëlle
Bégaud, Bernard
Praet, Nicolas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40264-020-00984-7
- URN
-
urn:nbn:de:101:1-2020120511293391849128
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Arlegui, Hugo
- Bollaerts, Kaatje
- Salvo, Francesco
- Bauchau, Vincent
- Nachbaur, Gaëlle
- Bégaud, Bernard
- Praet, Nicolas
- SpringerLink (Online service)
Other Objects (12)
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
Benefit–Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project
Risk–benefit and cost–benefit ratio in headache treatment
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project
Predicting Regulatory Product Approvals Using a Proposed Quantitative Version of FDA’s Benefit–Risk Framework to Calculate Net-Benefit Score and Benefit–Risk Ratio
Exploring the Cost-Benefit of Vaccines for Infectious Diseases in Slaughter Pig Production
Joint distribution approaches to simultaneously quantifying benefit and risk
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management
Malaria Vaccines: Progress to Date
Anaphylaxis to additives in vaccines
Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
Veterinary vaccines
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
Benefit–Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project
Risk–benefit and cost–benefit ratio in headache treatment
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project
Predicting Regulatory Product Approvals Using a Proposed Quantitative Version of FDA’s Benefit–Risk Framework to Calculate Net-Benefit Score and Benefit–Risk Ratio
Exploring the Cost-Benefit of Vaccines for Infectious Diseases in Slaughter Pig Production
Joint distribution approaches to simultaneously quantifying benefit and risk
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management
Malaria Vaccines: Progress to Date
Anaphylaxis to additives in vaccines
Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
Veterinary vaccines
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
Benefit–Risk Monitoring of Vaccines Using an Interactive Dashboard: A Methodological Proposal from the ADVANCE Project
Risk–benefit and cost–benefit ratio in headache treatment
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project
Predicting Regulatory Product Approvals Using a Proposed Quantitative Version of FDA’s Benefit–Risk Framework to Calculate Net-Benefit Score and Benefit–Risk Ratio
Exploring the Cost-Benefit of Vaccines for Infectious Diseases in Slaughter Pig Production
Joint distribution approaches to simultaneously quantifying benefit and risk
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management
Malaria Vaccines: Progress to Date
Anaphylaxis to additives in vaccines
Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth